A First-in-Human Safety Trial of MTX-463
Clinical trial NCT06401213 · COMPLETED
Trial details
- NCT number
- NCT06401213
- Sponsor
- Mediar Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-15
- Primary completion
- 2024-11-15
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.